A potential rush of treatment options on the horizon for non-alcoholic steatohepatitis will require skillful maneuvering in this likely lucrative but uncharted therapeutic market.
Jayachandra Reddy and Rishit Thakkar
Advertisement
Jayachandra Reddy has an extensive pharmaceutical background, covering strategic consulting and commercial analytics. Rishit Thakkar is a professional with over 10 years' experience in Research and Analytics. Jayachandra is a Senior Director at phamax, where Rishit also works as a Senior Project Manager. phamax is a dedicated research platform for scientific and analytical market access solutions.
Articles by Jayachandra Reddy and Rishit Thakkar
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Advertisement
Latest Updated Articles
Strategies for Successful Market Access in the Untapped NASH MarketPublished: October 3rd 2017 | Updated:
Navigating the Untapped NASH MarketPublished: November 1st 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
